Summary
Cardinal Health, Inc. (CAH) filed an 8-K on October 6, 2008, to report the resolution of a significant legal matter concerning the suspension of licenses to distribute controlled substances at three of its distribution centers. The company has entered into settlement agreements with the U.S. Drug Enforcement Administration (DEA) and seven U.S. Attorneys’ Offices, which will lead to the reinstatement of these crucial licenses. This development is important for investors as it resolves a previously disclosed issue that impacted the company's operations. The settlement includes the company's commitment to maintaining a robust compliance program focused on preventing the diversion of controlled substances. While a settlement amount of $34 million will be paid, it's crucial to note that Cardinal Health had already fully reserved for this amount in fiscal year 2008, mitigating any unexpected financial impact from this specific payment.
Key Highlights
- 1Cardinal Health has reached settlement agreements with the DEA and seven U.S. Attorneys' Offices.
- 2These agreements will result in the reinstatement of suspended licenses to distribute controlled substances at three distribution centers.
- 3The company committed to maintaining a compliance program to detect and prevent diversion of controlled substances.
- 4Cardinal Health will pay a settlement amount of $34 million.
- 5The $34 million settlement was fully reserved for in fiscal year 2008, indicating no additional financial burden beyond prior provisions.
- 6The resolution addresses a key operational risk previously disclosed in the company's Form 10-K for fiscal year 2008.